151 related articles for article (PubMed ID: 838039)
1. [Action of nicergoline on the cerebral circulatory insufficiency due to arteriosclerosis. Clinical and angioserographic evaluation].
Bernini FP; Muras I; Maglione F; Smaltino F
Farmaco Prat; 1977 Jan; 32(1):32-46. PubMed ID: 838039
[No Abstract] [Full Text] [Related]
2. [Current treatment of cerebrovascular disorder with vasoactive drugs].
Lebiediewa NW
Neurol Neurochir Pol; 1981; 15(4):417-21. PubMed ID: 6895779
[TBL] [Abstract][Full Text] [Related]
3. [The effect of nicergoline on the systemic and cerebral hemodynamics of patients with circulatory encephalopathy and an atherosclerotic lesion of the major cerebral arteries].
Ishchenko MM; Shkrobot SI
Lik Sprava; 1992 Oct; (10):100-2. PubMed ID: 1485425
[TBL] [Abstract][Full Text] [Related]
4. [Effects of nicergoline on hemodynamics and metabolism of the brain in primary arterial hypertension and in arteriosclerosis].
Maiolo AT; Bianchi Porro G; Galli C; Sessa M
Clin Ter; 1972 Aug; 62(3):239-52. PubMed ID: 5081153
[No Abstract] [Full Text] [Related]
5. [Polygraphic evaluation of a new vasoactive drug (nicergoline)].
Baturic P; Cirignotta F
Minerva Cardioangiol; 1973 Oct; 21(10):664-7. PubMed ID: 4589189
[No Abstract] [Full Text] [Related]
6. [The effect of sermion on the main hemodynamic indices in patients with the initial manifestations of cerebral atherosclerosis].
Tokar' AV; Akhaladze NG; Ena LM; Rudaia ES; Severova NL
Vrach Delo; 1990 Feb; (2):27-30. PubMed ID: 2339544
[TBL] [Abstract][Full Text] [Related]
7. [Serial angiographic evaluation of the effects of various vasoactive drugs on cerebral circulation in man].
Bernini FP; Smaltino F
Acta Neurol (Napoli); 1974 Mar; 29(2):170-84. PubMed ID: 4849693
[No Abstract] [Full Text] [Related]
8. [Effects of nicergoline on cerebral blood flow (author's transl)].
Iliff LD; Du Boulay GH; Marshall J; Ross Russell RW; Symon L
Arzneimittelforschung; 1979; 29(8a):1277-8. PubMed ID: 540071
[TBL] [Abstract][Full Text] [Related]
9. [Therapeutic action of nicergoline in the treatment of cerebrovascular and peripheral disorders].
Pasotti C; Liverta C; Cacciatori D; Pollini C
Farmaco Prat; 1974 Sep; 29(9):508-19. PubMed ID: 4608968
[No Abstract] [Full Text] [Related]
10. [The effect of pentoxifylline and nicergoline on the systemic and cerebral hemodynamics and on the blood rheological properties in patients with an ischemic stroke and atherosclerotic lesions of the major cerebral arteries].
Gara II
Zh Nevrol Psikhiatr Im S S Korsakova; 1993; 93(3):28-32. PubMed ID: 8042384
[TBL] [Abstract][Full Text] [Related]
11. [Influence of nicergoline on the cerebral blood flow and alpha-sympatholytical properties (author's transl)].
Lievre M; Ollagnier M; Faucon G
Arzneimittelforschung; 1979; 29(8a):1227-31. PubMed ID: 44198
[TBL] [Abstract][Full Text] [Related]
12. [Comparative activity in the unanesthetized rabbit, of nicergoline and papaverine adenylate and 5-pyridoxal phosphate on local cerebral blood flow].
Beaughard M; Cosnier D; Labrid C
Therapie; 1978; 33(4):475-90. PubMed ID: 734627
[No Abstract] [Full Text] [Related]
13. [Value of nicergoline in postischemic cerebral resuscitation. An experimental study in the dog].
Cahn R; Weber S; Angignard J; Angignard D; Borzeix MG
Agressologie; 1987 Mar; 28(3):341-6. PubMed ID: 3618895
[No Abstract] [Full Text] [Related]
14. [Effects of nicergoline on cerebral energy metabolism in normal mice].
Shintomi K; Yoshimoto K; Ogawa Y; Itakura T; Fukushima T; Matsumoto M; Matsuoka Y; Ishida R
Yakugaku Zasshi; 1986 Jan; 106(1):90-4. PubMed ID: 3009777
[No Abstract] [Full Text] [Related]
15. [Use of sermion in cerebral atherosclerosis patients with a history of ischemic stroke].
Tsimenko OA; Sosnov IuD; Kharchenko AP; Gaĭduk IuS
Vrach Delo; 1988 Jul; (7):24-7. PubMed ID: 3188456
[No Abstract] [Full Text] [Related]
16. A comparison of some of the pharmacological properties of the new eburnamenine derivative vindeburnol with those of vincamine, vinburnine, dihydroergotoxine mesilate and nicergoline.
Barzaghi F; Dragonetti M; Formento ML; Gueniau C; Nencioni A; Mantegazza P
Arzneimittelforschung; 1986 Oct; 36(10):1442-8. PubMed ID: 3814205
[TBL] [Abstract][Full Text] [Related]
17. Cerebroprotective effect of nicergoline and interference with the anti-hypoxic effect of prostacyclin.
Nikolov R; Dikova M; Nikolova M; Voronina T; Nerobkova L; Garibova T
Methods Find Exp Clin Pharmacol; 1987 Aug; 9(8):479-84. PubMed ID: 3320632
[TBL] [Abstract][Full Text] [Related]
18. Effects of nicergoline in experimental models related to pathogenesis of migraine.
Mirzoyan RS; Ganshina TS; Pukhalskaya TG; Volobueva TI; Vedernikov YP; Dikova M; Nikolova M; Nikolov R
Methods Find Exp Clin Pharmacol; 1989 Nov; 11(11):671-6. PubMed ID: 2622296
[TBL] [Abstract][Full Text] [Related]
19. [Effectiveness of nicergoline in the treatment of chronic cerebrovascular insufficiency (author's transl)].
Kaemmerer E
Nervenarzt; 1980 Jun; 51(6):368-72. PubMed ID: 7453888
[No Abstract] [Full Text] [Related]
20. [Platelet aggregation activity. Inhibitory effects of an alpha-blocking agent: nicergoline].
Migne J; Saint-Maurice JP; Santonja R; Kunz S
Sem Hop Ther; 1974 Dec; 50(10):649-55. PubMed ID: 4465915
[No Abstract] [Full Text] [Related]
[Next] [New Search]
